Official SEC submissions

BridgeBio Pharma SEC Filings

Direct answer

BridgeBio Pharma's latest SEC filing is 8-K.

It was filed on October 13, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free BridgeBio Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

8-K

Current report

Filed: 2026-10-13

Report date: 2026-10-06

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-09-21

Report date: 2026-09-17

FORM 4

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-31

Report date: 2026-08-31

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-08-20

Report date: 2026-08-18

FORM 4

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-08-19

Open SEC document View filing index

Insider transaction

Filed: 2026-08-18

Report date: 2026-08-16

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-08-18

Report date: 2026-08-16

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-08-18

Report date: 2026-08-16

FORM 4

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-08-18

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-08-17

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-17

Report date: 2026-08-13

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-08-10

Report date: 2026-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-08-10

Report date: 2026-08-10

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-08-03

Report date: 2026-07-30

FORM 4

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-22

Report date: 2026-07-22

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-07-13

Report date: 2026-07-09

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-07-13

Report date: 2026-07-09

FORM 4

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-07-09

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-07-09

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-02

Report date: 2026-07-01

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-26

Report date: 2026-06-22

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

Insider transaction

Filed: 2026-06-24

Report date: 2026-06-22

FORM 4

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-24

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-24

Open SEC document View filing index

Insider transaction

Filed: 2026-06-23

Report date: 2026-06-20

FORM 4

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-23

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-23

Open SEC document View filing index

144

Planned securities sale

Filed: 2026-06-22

Open SEC document View filing index

Insider transaction

Filed: 2026-06-17

Report date: 2026-06-15

FORM 4

Open SEC document View filing index

Verified data

Recent filing categories: 4
Recent filings: 40
SEC CIK: 0001743881
Latest filing date: October 13, 2026

Explore related company data

View the BridgeBio Pharma company profile View BridgeBio Pharma annual financials